Aura Biosciences (AURA) Profit After Tax (2020 - 2026)

Aura Biosciences (AURA) has 7 years of Profit After Tax data on file, last reported at -$33.7 million in Q1 2026.

• Quarterly Profit After Tax fell 22.57% year-over-year to -$33.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$112.7 million (down 54.11% YoY) and the FY2025 annual result came in at -$106.6 million, down 22.2% from the prior year.
• Profit After Tax retreated to -$33.7 million in Q1 2026, from -$25.9 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $790000.0 in Q3 2024 to a low of -$33.7 million in Q1 2026.
• A 5-year average of -$18.9 million and a median of -$19.7 million in 2024 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2024 — Profit After Tax soared 787.64% — and 2025, when it plunged 3402.03%.
• Tracing AURA's Profit After Tax over 5 years: stood at -$16.4 million in 2022, then tumbled by 34.85% to -$22.1 million in 2023, then declined by 17.98% to -$26.1 million in 2024, then advanced by 0.71% to -$25.9 million in 2025, then decreased by 29.94% to -$33.7 million in 2026.
• The last three Profit After Tax figures came in at -$33.7 million (Q1 2026), -$25.9 million (Q4 2025), and -$26.1 million (Q3 2025), per Business Quant data.